Abstract
The 3e Initiative (Evidence, Expertise, Exchange) is a multinational task force devoted to producing evidence-based recommendations for daily clinical practice in Rheumatology. It is a combination of systematically generated evidence and expert opinions of an international panel of rheumatologists. Since 2006, the 3e initiative has addressed successively the management of Ankylosing Spondylitis1, the use of Methotrexate in Rheumatoid Arthritis2, and the management of patients with Undifferentiated Peripheral Inflammatory Arthritis (UPIA)3, resulting in multinational recommendations on these topics. The 2010 3e collaboration’s objective was to elaborate recommendations on how to manage musculoskeletal pain by pharmacotherapy in inflammatory arthritis, which …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
